GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients
Crossref DOI link: https://doi.org/10.1007/s10072-015-2427-3
Published Online: 2015-11-30
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Marcotulli, Christian
Fortuni, Silvia
Arcuri, Gaetano
Tomassini, Barbara
Leonardi, Luca
Pierelli, Francesco
Testi, Roberto
Casali, Carlo
Text and Data Mining valid from 2015-11-30